References:
1 Sharma ST, Nieman LK, Feelders RA. Cushing’s syndrome: epidemiology and developments in disease management. Clinical epidemiology. 2015;7:281.
2 Buliman A, Tataranu LG, Paun DL, Mirica A, Dumitrache C. Cushing’s disease: a multidisciplinary overview of the clinical features, diagnosis, and treatment. Journal of medicine and life. 2016 Jan;9(1):12.
3 Pappachan JM, Hariman C, Edavalath M, Waldron J, Hanna FW. Cushing’s syndrome: a practical approach to diagnosis and differential diagnoses. Journal of clinical pathology. 2017 Apr 1;70(4):350-9.
4.Oronsky B, Ma PC, Morgensztern D, Carter CA. Nothing but NET: a review of neuroendocrine tumors and carcinomas. Neoplasia. 2017 Dec 1;19(12):991-1002.
5 Filosso PL, Ruffini E, Solidoro P, Roffinella M, Lausi PO, Lyberis P, Oliaro A, Guerrera F. Neuroendocrine tumors of the thymus. Journal of thoracic disease. 2017 Nov;9(Suppl 15):S1484.
6 Rosai J, Higa E. Mediastinal endocrine neoplasm, of probable thymic origin, related to carcinoid tumor. Clinicopathologic study of 8 cases. Cancer. 1972 Apr;29(4):1061-74.
7 Lawrence L, Zhang P, Choi H, Ahmad U, Arrossi V, Purysko A, Makin V. A unique case of ectopic Cushing’s syndrome from a thymic neuroendocrine carcinoma. Endocrinology, diabetes & metabolism case reports. 2019 Feb 22;2019(1).
8  Chaer R, Massad MG, Evans A, Snow NJ, Geha AS. Primary neuroendocrine tumors of the thymus. The Annals of thoracic surgery. 2002 Nov 1;74(5):1733-40.
Figures legends: figure 1: axial contrast-enhanced CT Study at the level of mid-thoracic regions shows a small peripherally enhancing solid abnormality within the thymus (Circle figure 2: Axial contrast-enhanced CT study at the level of the upper abdomen shows a smooth enlargement of both adrenal glands in keeping with hypertrophy ( arrows)